Pharmaceutical composition containing novel spiro compound
JP2024159693APending Publication Date: 2024-11-08TANABE PHARMA CORP
Patent Information
- Application Number
- JP2024072088
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-28
- Filing Date
- 2024-04-26
- Publication Date
- 2024-11-08
Smart Images

Figure 2024159693000001 
Figure 2024159693000002 
Figure 2024159693000003
Abstract
To provide a pharmaceutical composition or the like that contains novel spiro compound which has inhibitory activity of TRH-DE, and is useful for preventing / treating TRH-involved various diseases and / or symptoms associated with the diseases, or a pharmacologically acceptable salt thereof as an active ingredient.SOLUTION: A pharmaceutical composition contains a compound expressed by a general formula [I]: [in the formula, a ring A denotes substituted / unsubstituted aryl, substituted / unsubstituted heteroaryl, substituted / unsubstituted aliphatic heterocycle; R1, R2 denote substituted / unsubstituted alkyl, substituted / unsubstituted cycloalkyl group, substituted / unsubstituted alkenyl, substituted / unsubstituted cycloalkenyl, substituted / unsubstituted alkynyl, substituted / unsubstituted aryl, substituted / unsubstituted heteroaryl, substituted / unsubstituted aliphatic heterocyclic group which may include double bond in a part of the ring, substituted / unsubstituted amino group or the like], or a pharmacologically acceptable salt thereof as an active ingredient.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art
Citation Information
Patent Citations
TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme
WO2001060843A1
Compounds that modulate TRH actions and inhibit the TRH-degrading enzyme
WO2006038206A2
Methods for modulating the levels and effects of thyrotropin-releasing hormone (TRH) and TRH-related petides
WO2007113784A2
